|
|
|
IVUS
|
A particularly valuable tool, Intravascular ultrasound (IVUS) technology uses high frequency sound waves to detect blood vessel blockages and other problems such as aneurysms. Cath Lab Digest reviews the uses of IVUS technology in the articles below. |
|
New IVUS Codes from CMS: A Win for Hospitals, Physicians, Patients and Medicare
New IVUS Codes from CMS: A Win for Hospitals, Physicians, Patients and Medicare Feature: New IVUS Codes from CMS: A Win for Hospitals, Physicians, Patients and Medicare - John McB. Hodgson, MD, FSCAI, FACC New IVUS Codes Were Adopted October 1 On October 1, 2004, Medicare adopted new intravascular ultrasound (IVUS) inpatient ICD-9-CM procedure codes to more accurately reflect the use of IVUS in hospitals. More accurate reimbursement for IVUS procedures may be possible as Medicare obtains ...
|
Stent Thrombosis: A Wake-Up Call?
Along with discontinued anti-platelet therapy, researchers are looking into the role of stent positioning and its association with stent thrombosis. What do we know so far?
|
Drug-Eluting Stent Outcomes with IVUS
This monthly column in Cath Lab Digest reviews important points of distinction with drug-eluting stents, from characteristics to interventional techniques, to provide valuable and relevant information about this technology. This article, the first of a two-part series on drug-eluting stent (DES) outcomes, focuses on the use of intravascular ultrasound (IVUS) during an angioplasty procedure.
|
Vascular Imaging Solutions
This monthly column in Cath Lab Digest reviews important points of distinction in vascular imaging, from characteristics to techniques, so that physicians and staff have valuable and relevant information about this revolutionary technology.
|
VASCULAR IMAGING SOLUTIONS: IVUS Training for Cath Lab Staff
This monthly column in Cath Lab Digest reviews important points of distinction in vascular imaging, from characteristics to techniques, so that physicians and cath lab professionals have valuable and relevant information about this revolutionary technology.
|
The Perfect Fit: Getting the Most Out of Your Coronary Stent
Post-dilatation Early-generation balloon-expandable stents were delivered with compliant balloons and required post-dilatation with noncompliant balloons at higher pressure to optimize stent deployment. These include: 1. IVUS for assessment of the lesion pre-stenting and verification of apposition and expansion post-stenting; 2. Pre-dilatation balloon catheters, the Cutting Balloon Device and rotational atherectomy for lesion preparation to optimize stent deployment; and 3. Noncompliant post...
|
In Search of the Vulnerable Stenosis: Imaging the Coronary Artery ? Lumen, Wall and Plaque Part 2 of 2
Tools to identify a vulnerable plaque, one which is likely to cause near-term acute myocardial infarction and adverse clinical sequelae, including sudden death, are currently limited to angiography and intravascular ultrasound (IVUS) imaging. Within the next decade, however, additional revolutionary, catheter-based techniques will emerge to identify, characterize, and treat the vulnerable plaque. This review will discuss three potential catheter-based modalities ? ultrasound, light, and thermal activity ? for imaging the vulnerable plaque, as well as current methods.
|
A Novel Device for Immediate Measurement of Arterial Lumen Cross-Sectional Area During Percutaneous Coronary or Peripheral Intervention Using Impedance Electrodes: The LumenRECON
This novel catheter uses electrical impedance to measure luminal cross-sectional area (CSA) prior to or after angioplasty for stent sizing and deployment. It also has potential applications for plaque characterization.
|
DES Controversy: Are We Asking the Wrong Questions?
Abstract. Studies comparing stents and optimizing post-procedural anti-platelet regimens abound. We should re-focus on optimizing stent deployment and maintaining a registry of how we are using and deploying drug-eluting stents.
|
Clinical and Industry News for May 2007
Some Patients Who Must Pay Part of Statin Costs Discontinue Use Some patients required to partially pay for statins stop taking the potentially lifesaving, cholesterol-lowering drugs, according to a U.S. study of a Canadian system reported in Circulation: Journal of the American Heart Association. Compared to patients in the full-coverage group, 5.4 percent of patients who started statin treatment three months after introduction of either the co-pay and co-insurance plans stopped or reduced ...
|
|
|
|
|
|
|
|
On Demand Medical Education
|
|
|
|
|
